CYP2D6 polymorphisms influence tamoxifen treatment outcomes in
Por um escritor misterioso
Descrição
The frequencies of CYP2D6 alleles and their impact on clinical outcomes of adjuvant tamoxifen therapy in Syrian breast cancer patients, BMC Cancer
Impact of duration (months, a), age (year, b), and CYP2D6 genotype (UM
Role of CYP2D6 and other CYP enzymes in the metabolism of tamoxifen to
CYP2D6 testing in breast cancer: ready for prime time? - Abstract - Europe PMC
Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response?, Expert Reviews in Molecular Medicine
Clinical Relevance of CYP2D6 Genetics for Tamoxifen Response in Breast Cancer
CYP2D6 Genotyping for Personalized Therapy of Tamoxifen in Indonesian Women with ER+ Breast Cancer
PDF) Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen
CYP2D6 and adjuvant tamoxifen: possible differences of outcome in pre- and post-menopausal patients
The frequencies of CYP2D6 alleles and their impact on clinical outcomes of adjuvant tamoxifen therapy in Syrian breast cancer patients, BMC Cancer
de
por adulto (o preço varia de acordo com o tamanho do grupo)
